Steven K. Laughlin

Development of Orally Bioavailable Bicyclic Pyrazolones as Inhibitors of Tumor Necrosis Factor-α Production

Michael P. Clark, Steven K. Laughlin, Matthew J. Laufersweiler et al. · Journal of Medicinal Chemistry · 2004 · 130 citations · Full text

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Michael P. Clark, Kelly M. George, Roger G. Bookland et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 55 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +8

The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-α) production

Steven K. Laughlin, Michael P. Clark, Jane F. Djung et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 53 citations

Inflammation, Anti-inflammatory, Medicine +10

Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3

Jack J. Chen, Kumar Thakur, Michael P. Clark et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 36 citations · Full text

Medicinal Chemistry, Medicine, Receptor Tyrosine Kinase +5

The development of monocyclic pyrazolone based cytokine synthesis inhibitors

Adam Gołȩbiowski, Jennifer A. Townes, Matthew J. Laufersweiler et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 27 citations

Medicinal Chemistry, Medicine, Immunology +6